Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Expert Opinion on Emerging Drugs
|
November 23, 2019
Emerging serine-threonine kinase inhibitors for treating ovarian cancer
Asaf Maoz, Marcia A Ciccone, Shinya Matsuzaki, et al.
American Journal of Hematology
|
December 22, 2018
Bortezomib ocular toxicities: Outcomes with ketotifen
Michael Dennis, Asaf Maoz, David Hughes, et al.
Expert Opinion on Investigational Drugs
|
April 22, 2016
Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature
Marcia A Ciccone, Asaf Maoz, Jennifer K Casabar, et al.
Gynecologic Oncology
|
November 16, 2020
Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer
Koji Matsuo, Shinya Matsuzaki, David J Nusbaum, et al.
Cancers
|
June 4, 2020
Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review
Asaf Maoz, Koji Matsuo, Marcia A Ciccone, et al.
JCO Precision Oncology
|
April 28, 2025
Intratumoral Heterogeneity of Mismatch Repair Status and Outcome of Treatment With Dostarlimab in a Patient With Locally Advanced Rectal Adenocarcinoma
Asaf Maoz, Ronald Bleday, Jeffrey Goldsmith, et al.
JCO Precision Oncology
|
October 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era
Asaf Maoz, Leah Biller, Marios Giannakis, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
The Journal of Clinical Investigation
|
March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Journal for Immunotherapy of Cancer
|
September 28, 2021
Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
Asaf Maoz, Carter Merenstein, Yusuke Koga, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Expert Opinion on Emerging Drugs
|
November 23, 2019
Emerging serine-threonine kinase inhibitors for treating ovarian cancer
Asaf Maoz, Marcia A Ciccone, Shinya Matsuzaki, et al.
American Journal of Hematology
|
December 22, 2018
Bortezomib ocular toxicities: Outcomes with ketotifen
Michael Dennis, Asaf Maoz, David Hughes, et al.
Expert Opinion on Investigational Drugs
|
April 22, 2016
Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature
Marcia A Ciccone, Asaf Maoz, Jennifer K Casabar, et al.
Gynecologic Oncology
|
November 16, 2020
Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer
Koji Matsuo, Shinya Matsuzaki, David J Nusbaum, et al.
Cancers
|
June 4, 2020
Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review
Asaf Maoz, Koji Matsuo, Marcia A Ciccone, et al.
JCO Precision Oncology
|
April 28, 2025
Intratumoral Heterogeneity of Mismatch Repair Status and Outcome of Treatment With Dostarlimab in a Patient With Locally Advanced Rectal Adenocarcinoma
Asaf Maoz, Ronald Bleday, Jeffrey Goldsmith, et al.
JCO Precision Oncology
|
October 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era
Asaf Maoz, Leah Biller, Marios Giannakis, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
The Journal of Clinical Investigation
|
March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Journal for Immunotherapy of Cancer
|
September 28, 2021
Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
Asaf Maoz, Carter Merenstein, Yusuke Koga, et al.
Page
of 3